Citius Oncology Inc
NASDAQ:CTOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Citius Oncology Inc
NASDAQ:CTOR
|
US |
|
Rudrabhishek Enterprises Ltd
NSE:REPL
|
IN |
|
I
|
Intensity Therapeutics Inc
NASDAQ:INTS
|
US |
Shareholder Yield
Current shareholder yield for CTOR is .
Peers Comparison
Shareholder Yield
Price Appreciation
CTOR Price
Citius Oncology Inc
| Average Annual Return | -97.06% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -99% |
| Market Capitalization | 58.2m USD |
| Shares Outstanding | 92 980 000 |
| Percentage of Shares Shorted | 1.8% |